http://bmj.com/cgi/content/full/324/7352/1493
| Home | Help | Search/Archive | Feedback | Table of Contents |
|
|
||||||
|
|
S G M Edwards
a Neurorehabilitation Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, b Institute of Neurology, National Hospital for Neurology and Neurosurgery, c Derriford Hospital, Plymouth PL6 8DH
Correspondence to: A J Thompson A.Thompson@ion.ucl.ac.uk
Rehabilitation aims to reduce the impact of disease, within the limitations imposed by available resources and the underlying disease.1 Measuring rehabilitation is difficult.2 Rating scales of impairment, disability, and handicap are often used but only partially reflect the rehabilitation process, tending to be "physician oriented."3 Rehabilitation is a patient based educational process working towards self management.2 Therefore, patient oriented measures should be used, as it is only the patients themselves who truly appreciate the impact of their illness,3 and the benefits from rehabilitation. The visual analogue scale is a patient based measuring tool that can be used to answer a variety of questions.
We evaluated how much the traditional, physician oriented measures reflect
the benefit perceived by patients, as measured on a visual analogue
scale, within the setting of a neurorehabilitation inpatient
unit.
| |
Participants, methods, and results |
|---|
|
|
|---|
Our study comprised 773 consecutive patients (mean age 47 (range 16-85) years) admitted to the National Hospital for Neurology and Neurosurgery's neurorehabilitation unit between June 1996 and May 2001. This 18 bed unit specialises in intensive, relatively short stay, individually tailored, goal oriented rehabilitation of patients with predominantly physical neurological deficits.4 We excluded 31 patients whose lengths of stay were less than 11 days (period of rehabilitation was not adequate). The median length of stay for the remaining 742 patients was 25 (11-149) days.
We categorised patients into four diagnostic groups: multiple sclerosis (305 patients), stroke (149), spinal cord syndromes (144), and all other conditions (144). Overall the patients improved significantly (P<0.001, paired t tests) on all physician outcome measures: functional independence measure motor score (58.6 (SD 19.2) at admission, 73.4 (17.2) at discharge), cognitive score (29.8 (6.4) v 31.2 (5.1)), total score (88.4 (22.0) v 104.6 (20.0)), and Barthel score (11.9 (5.2) v 16.1 (4.8)). Effect sizes were 0.76, 0.22, 0.73, and 0.80 respectively. Improvements in all four cohorts were similar.
At discharge, 682 patients were asked to rate their degree of perceived
benefit on a visual analogue scale, a line ranging from 0 to 10 (high
score indicates greater benefit). Patients with visual, cognitive, or
language deficits (n=60), unable to carry out the task, were
excluded. Patients' perceived benefit from rehabilitation programmes
was high, mean 8.3 (2.0) (multiple sclerosis 8.0, stroke 8.3, spinal
cord 8.5, others 8.5). Correlations of visual analogue scores and
disability change scores were low (Pearson's coefficient for change
in functional independence measure, motor score 0.240, cognitive
score 0.072, total score 0.238; Barthel score 0.278).
| |
Comment |
|---|
|
|
|---|
Physician outcome measures relate poorly with patients' perceived benefit from inpatient neurorehabilitation as measured on a visual analogue scale. Visual analogue scales are an established tool in the measurement of a range of symptoms, most notably pain. They have also been used to assess global outcome in stroke rehabilitation.5 They are quick and easy to administer but are susceptible to some bias, with some patients likely to give higher scores through a desire to please.
Patient based scores are likely to reflect functional improvement, and
patients in this study improved functionally and reported a high
level of perceived benefit on the visual analogue scale. The low
correlation of visual analogue scale with the functional outcome
measures indicates that these measures reflect only a small part of
patients' perceived benefit. Conventional outcome measures are likely
to underestimate the benefit of rehabilitation, with issues such as
patients' coping strategies and self efficacy being ignored. Work is
needed to more accurately define the areas of health that
rehabilitation affects, so that interventions and services can be
more specific and effective.
| |
Acknowledgments |
|---|
Contributors: SGME analysed the data. SGME and EDP drafted the article. JCH helped with interpretation of the data and statistical analysis. AJT was responsible for the concept and design and is guarantor for the study.
| |
Footnotes |
|---|
Funding: None
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. | Wade DT. Measurement in neurological rehabilitation. Oxford: Oxford University Press, 1992. |
| 2. | Wade DT, de Jong BA. Recent advances in rehabilitation. BMJ 2000; 320: 1385-1388[Full Text]. |
| 3. | Hobart JC, Freeman JA, Lamping DL. Physician and patient-oriented outcomes in progressive neurological disease: which to measure? Curr Opin Neurol 1996; 9: 441-444[Medline]. |
| 4. | Freeman JA, Playford ED, Nicholas RS, Thompson AJ. A neurological rehabilitation unit: audit of activity and outcome. J R Coll Phys Lond 1996; 30: 21-26. |
| 5. | Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL. Stroke unit treatment improves long-term quality of life: a randomized controlled trial. Stroke 1998; 29: 895-899[Abstract/Full Text]. |
(Accepted 21 May 2002)
|
|
||||||
|
|
| Home | Help | Search/Archive | Feedback | Table of Contents |
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.